Back

Watch Compare

STRATA Skin Sciences, Inc.

Data quality: 100%

SSKN

OTC Manufacturing Measuring & Analyzing Instruments

$0.17

▼ $0.03 (-15.00%)

Mkt Cap: 1.00 M

Price

$0.17

Mkt Cap

1.00 M

Day Range

$0.17 — $0.17

52-Week Range

$0.12 — $3.86

Volume

117

Open $0.17

50D / 200D Avg

$0.52

67.22% below

50D / 200D Avg

$1.45

88.29% below

Quick Summary

Key Takeaways

Revenue grew 0.59% annually over 5 years — modest growth

Debt/Equity of 11.65 — high leverage

Negative free cash flow of -4.26 M

Revenue growth is decelerating — 1Y growth trails 5Y average by 9.13%

Capital efficient — spends only 4.78% of revenue on capex

Growth

Revenue Growth (5Y)

0.59%

Below sector avg (1.82%)

Revenue (1Y)-8.54%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-772.01%

Below sector avg (-53.41%)

ROIC-22.92%

Net Margin-20.40%

Op. Margin-15.31%

Safety

Debt / Equity

11.65

Above sector avg (0.31)

Current Ratio0.95

Interest Coverage-2.40

Valuation

PE (TTM)

-0.16

Above sector avg (-1.48)

P/B Ratio0.76

EV/EBITDAN/A

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	-0.2	-1.5
P/B	0.8	1.6
ROE %	-772.0	-53.4
Net Margin %	-20.4	-41.5
Rev Growth 5Y %	0.6	1.8
D/E	11.7	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-8.54%	Revenue Growth (3Y)	-4.07%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	0.59%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	30.70 M	Net Income (TTM)	-6.26 M
ROE	-772.01%	ROA	-20.38%
Gross Margin	58.25%	Operating Margin	-15.31%
Net Margin	-20.40%	Free Cash Flow (TTM)	-4.26 M
ROIC	-22.92%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	11.65	Current Ratio	0.95
Interest Coverage	-2.40	Asset Turnover	1.00
Working Capital	-761,000	Tangible Book Value	-4.34 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.16	Forward P/E	N/A
P/B Ratio	0.76	P/S Ratio	0.03
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-425.53%
Market Cap	1.00 M	Enterprise Value	9.24 M
Per Share
EPS (Diluted TTM)	-1.35	Revenue / Share	5.21
FCF / Share	-0.72	OCF / Share	-0.47
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	4.78%	FCF Conversion	68.07%
SBC-Adj. FCF	-4.76 M	Growth Momentum	-9.13

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	30.70 M	33.56 M	33.36 M	36.16 M	29.98 M
Net Income	-6.26 M	-10.09 M	-10.83 M	-5.55 M	-2.71 M
EPS (Diluted)	-1.35	-2.65	-0.31	—	—
Gross Profit	17.88 M	19.08 M	18.46 M	21.77 M	19.85 M
Operating Income	-4.70 M	-9.26 M	-8.60 M	-4.65 M	-4.40 M
EBITDA	—	—	—	—	—
R&D Expenses	421,000.0	883,000.0	1.32 M	1.03 M	1.43 M
SG&A Expenses	—	—	—	—	—
D&A	4.12 M	4.97 M	5.55 M	2.40 M	2.10 M
Interest Expense	1.96 M	2.11 M	1.64 M	926,000.0	314,000.0
Income Tax	12,000.0	-170,000.0	-92,000.0	63,000.0	34,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	30.52 M	36.16 M	42.02 M	52.27 M	46.59 M
Total Liabilities	27.61 M	31.19 M	29.33 M	30.44 M	21.18 M
Shareholders' Equity	2.91 M	4.97 M	12.69 M	21.83 M	25.41 M
Total Debt	15.35 M	15.00 M	15.00 M	8.00 M	8.00 M
Cash & Equivalents	7.91 M	7.26 M	6.78 M	5.43 M	12.59 M
Current Assets	15.60 M	16.60 M	15.54 M	17.50 M	19.97 M
Current Liabilities	26.74 M	14.63 M	12.17 M	13.43 M	12.80 M